Eli Lilly to seek approval of obesity drug that could disrupt weight loss market - Financial Times
- Eli Lilly to seek approval of obesity drug that could disrupt weight loss market Financial Times
- Powerful new obesity drug poised to upend weight loss care Yahoo News
- Diabetes drug Mounjaro could be FDA approved for weight loss by late 2023: Eli Lilly ABC News
- Eli Lilly says obesity drug tirzepatide resulted in weight loss of up to 34 pounds CNBC
- Diabetic medication awaiting FDA approval for weight-loss WHIO
- View Full Coverage on Google News